OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 73 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36,688 | -36.0% | 10,573 | -54.8% | 0.01% | -44.4% |
| Q4 2022 | $57,364 | -43.2% | 23,414 | -35.9% | 0.01% | -40.0% |
| Q3 2022 | $101,000 | -73.1% | 36,541 | -60.4% | 0.02% | -54.5% |
| Q2 2022 | $376,000 | -27.8% | 92,354 | -24.5% | 0.03% | -26.7% |
| Q1 2022 | $521,000 | +120.8% | 122,358 | +386.1% | 0.04% | +150.0% |
| Q4 2021 | $236,000 | – | 25,169 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $103,181,000 | 7.44% |
| BVF INC/IL | 6,661,503 | $183,591,000 | 7.16% |
| VR Adviser, LLC | 1,536,193 | $42,337,000 | 5.44% |
| Cormorant Asset Management, LP | 3,073,485 | $84,705,000 | 3.44% |
| GREAT POINT PARTNERS LLC | 329,086 | $9,070,000 | 2.11% |
| Vivo Capital, LLC | 1,238,575 | $34,135,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 150,500 | $4,148,000 | 1.46% |
| Foresite Capital Management IV, LLC | 342,030 | $9,426,000 | 1.39% |
| RA Capital Management | 2,150,404 | $59,265,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 338,381 | $9,326,000 | 0.78% |